Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk

Movement Disorders

Volumn 29, Issue 1, 2014, Pages 105-114

  Fisher, Emily R ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ascertainment; Epidemiology; Huntington disease; Population at risk; Prevalence

Indexed keywords

ADULT; ARTICLE; CANADA; CAUCASIAN; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HEALTH CARE DELIVERY; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; HUNTINGTON DISEASE LIKE SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL GENETICS; MEDICAL SERVICE; MIDDLE AGED; MORTALITY; NEUROLOGIC DISEASE; NURSING HOME; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; SOCIAL WORK;

ASCERTAINMENT; EPIDEMIOLOGY; HUNTINGTON DISEASE; POPULATION AT RISK; PREVALENCE;

ADULT; AGE OF ONSET; BRITISH COLUMBIA; CANADA; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PREVALENCE; RISK; YOUNG ADULT;

EID: 84892932050     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25717     Document Type: Article

References (30)

1. Morrison PJ. Prevalence estimates of Huntington's disease in Caucasian populations are gross underestimates. Mov Disord 2012;27:1707-1708.
2. Pringsheim T. Reply: Prevalence estimates of Huntington's disease in Caucasian populations are gross underestimates. Mov Disord 2012;27:1708-1709.
3. Pringsheim T, Wiltshire K, Day L, et al. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord 2012;27:1083-1091.
4. Warren G, Yellowlees P. The prevalence of Huntington's disease. Med J Aust 1990;153:629.
5. Morrison PJ, Nevin NC. Huntington disease in County Donegal: epidemiological trends over four decades. Ulster Med J 1993;62:141-144.
6. MacMillan JC, Snell RG, Tyler A, et al. Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet 1993;342:954-958.
7. Harper PS. Epidemiology. In: Bates G, Harper PS, Jones L, eds. Huntington's Disease, 3rd ed. Oxford, UK: Oxford University Press; 2002:159-197.
8. Rawlins, M. Huntington's disease out of the closet? Lancet Neurol 2010;376:1372-1373.
9. Evans SJW, Douglas I, Rawlins MD, et al. Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry 2013 March 12. doi: 10.1136/jnnp-2012-304636.
10. Tassicker RJ, Teltscher B, Kaye Trembath M, et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Euro J Hum Genet 2009;17:66-70.
11. Morrison PJ, Harding-Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet 2011;80:281-286.
12. Morrison PJ, Johnston WP, Nevin NC. The epidemiology of Huntington's disease in Northern Ireland. J Med Genet 1995;34:524-530.
13. BC Stats. Population estimates. January 2012. Available at: www.bcstats.gov.bc.ca/StatisticsBySubject/Demography/PopulationEstimates.aspx. Accessed on: 1 February 2013.
14. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
15. Orth M, Schwenke C. Age-at-onset in Huntington disease. PLoS Curr 2011;3:RRN1258. doi: 10.1371/currents.RRN1258.
16. Centre for Molecular Medicine and Therapeutics. Centre for Huntington Disease. January 2011. Available at: www.cmmt.ubc.ca/outreach/hd-clinic. Accessed on 27 January 2013.
17. Fox S, Bloch M, Fahy M, et al. Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia. Am J Med Genet 1989;32:211-216.
18. Von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808.
19. BC Laws. RSBC: 1996-Chapter 165. Freedom of Information and Protection of Privacy Act. Available at: www.bclaws.ca/EPLibraries/bclaws_new/document/LOC/freeside/section35. Accessed on 20 October 2012.
20. Kremer B, Goldberg P, Andrew SE, et al. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. N Engl J Med 1994;330:1401-1406.
21. Roos RA, Hermans J, Vegter-van der Vlis M, et al. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56:98-100.
22. Foroud T, Gray J, Ivashina J, Conneally P. Differences in duration of Huntington's disease based on age at onset. J Neurol Neurosurg Psychiatry 1999;66:52-56.
23. Massey University. Estimate prevalence: confidence interval. 2011. Available at: www.promesa.co.nz/Help/EP_est_simple_random_sample.htm. Accessed on 5 February 2012.
24. Barbeau A, Coiteux C, Trudeau J, et al. La Choree de Huntington chez le Canadiens Francais Etude Preliminaire. Union Med Can 1964;93:1178-1182.
25. Shokeir MHK. Investigations on Huntington's disease in the Canadian Prairies. 1. Prevalence. Clin Genet 1975;7:345-348.
26. CIA World Factbook. Life expectancy at birth. January 2012. Available at: www.cia.gov/library/publications/the-worldfactbook. html. Accessed on 7 February 2013.
27. Morrison PJ. Accurate prevalence and uptake for testing of Huntington's disease. Lancet 2010;9:1147.
28. Loy CT, Lownie A, McCusker E. Huntington's disease. Lancet 2010;376:1463.
29. Enroll -HD. A prospective registry study in a global HD cohort. January 2012. Available at: www.enroll-hd.org. Accessed on 7 February 2013.
30. Ehrnhoefer D, Wong BKY, Hayden MR. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. Nature Rev Drug Discov 2011;10:853-867.